Jeffs' Brands (JFBR) 6-K 30 Sep 24 Report of Foreign Private Issuer Financial data

Document And Entity Information

Document And Entity Information	6 Months Ended
	Jun. 30, 2024
Document Information Line Items
Entity Registrant Name	Jeffs’ Brands Ltd
Document Type	6-K
Current Fiscal Year End Date	--12-31
Amendment Flag	false
Entity Central Index Key	0001885408
Document Period End Date	Jun. 30, 2024
Document Fiscal Year Focus	2024
Document Fiscal Period Focus	Q2
Entity File Number	001-41482

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Jun. 30, 2024	Dec. 31, 2023
CURRENT ASSETS:
Cash and cash equivalents	$ 2,815	$ 535
Restricted deposit	17	17
Trade receivables	396	629
Other receivables	445	597
Related party receivables	53
Inventory	4,354	2,386
Total current assets	8,080	4,164
NON-CURRENT ASSETS:
Property and equipment, net	61	59
Investment accounted for using the equity method	1,695	1,940
Investment at fair value	11	67
Intangible assets, net	5,330	5,714
Deferred taxes	195	168
Operating lease right-of-use assets	86	127
Total non-current assets	7,378	8,075
TOTAL ASSETS	15,458	12,239
CURRENT LIABILITIES:
Trade payables	521	709
Other payables	1,293	1,533
Related party payables	31	66
Total current liabilities	1,845	2,308
NON-CURRENT LIABILITIES:
Derivative liabilities	6,406	1,375
Operating lease liabilities	14	45
Total non-current liabilities	6,420	1,420
TOTAL LIABILITIES	8,265	3,728
SHAREHOLDERS’ EQUITY:
Ordinary shares, no par value per share - Authorized: 43,567,567 as of June 30, 2024 and December 31, 2023; Issued and outstanding: 9,177,100 shares as of June 30, 2024; and 1,215,512 shares as of December 31, 2023
Additional paid-in-capital	19,344	16,787
Accumulated deficit	(12,151)	(8,276)
TOTAL SHAREHOLDERS’ EQUITY	7,193	8,511
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY	$ 15,458	$ 12,239

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Parentheticals) - $ / shares	Jun. 30, 2024	Dec. 31, 2023
Statement of Financial Position [Abstract]
Ordinary shares, par value (in Dollars per share)
Ordinary shares, Authorized	43,567,567	43,567,567
Ordinary shares, Issued	9,177,100	1,215,512
Ordinary shares, outstanding	9,177,100	1,215,512

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations Unaudited - USD ($) $ in Thousands		6 Months Ended
		Jun. 30, 2024	Jun. 30, 2023
Income Statement [Abstract]
Revenues	[1]	$ 6,198	$ 3,871
Cost of sales	[1]	5,441	3,498
Gross profit	[1]	757	373
Operating expenses:
Sales and marketing	[1]	603	342
General and administrative	[1]	2,413	2,067
Equity losses	[1]	245	89
Other income	[1]	(60)	(158)
Operating loss	[1]	(2,444)	(1,967)
Financial expenses (income), net	[1]	1,367	(148)
Loss before taxes	[1]	(3,811)	(1,819)
Tax expenses	[1]	64	9
Net loss for the period	[1]	$ (3,875)	$ (1,828)
Loss per ordinary share (basic and diluted) (in Dollars per share)	[1],[2]	$ (0.69)	$ (1.54)
Weighted-average ordinary shares used in computing net loss per share, basic and diluted (in Shares)	[1],[2]	5,586,274	1,173,097
[1] Except share and per share information Share and per share data in these condensed consolidated financial statements have been retroactively adjusted to reflect the reverse share split effected in November 2023.

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Changes in Shareholders’ Equity (Unaudited) - USD ($) $ in Thousands	Ordinary Shares	Additional paid-in- capital	Accumulated Deficit	Total
Balance at Dec. 31, 2022		$ 16,499	$ (3,678)	$ 12,821
Balance (in Shares) at Dec. 31, 2022	1,180,167
Net loss for the period			(1,828)	(1,828)	[1]
Issuance of ordinary shares to SciSparc Ltd. (see note 3b.)		288		288
Issuance of ordinary shares to SciSparc Ltd. (see note 3b.) (in Shares)	35,345
Balance at Jun. 30, 2023		16,787	(5,506)	11,281
Balance (in Shares) at Jun. 30, 2023	1,215,512
Balance at Dec. 31, 2023		16,787	(8,276)	$ 8,511
Balance (in Shares) at Dec. 31, 2023	1,215,512			1,215,512
Net loss for the period			(3,875)	$ (3,875)	[1]
Issuance of ordinary shares pre-funded warrants and warrants, net (note 4a.)		2,557		2,557
Issuance of ordinary shares pre-funded warrants and warrants, net (note 4a.) (in Shares)	1,884,461
Exercise of Series B Warrants (note 4a.)
Exercise of Series B Warrants (note 4a.) (in Shares)	5,257,127
Exercise of Pre-Funded Warrants (note 4a.)
Exercise of Pre-Funded Warrants (note 4a.) (in Shares)	820,000
Balance at Jun. 30, 2024		$ 19,344	$ (12,151)	$ 7,193
Balance (in Shares) at Jun. 30, 2024	9,177,100			9,177,100
[1] Except share and per share information

Condensed Consolidated Statem_3

Condensed Consolidated Statements of Cash Flows Unaudited - USD ($) $ in Thousands		6 Months Ended
		Jun. 30, 2024	Jun. 30, 2023
CASH FLOWS USED IN OPERATING ACTIVITIES:
Net loss for the period	[1]	$ (3,875)	$ (1,828)
Adjustments to reconcile net loss to net cash from (used in) operating activities:
Exchange differences on cash and cash equivalent		5	46
Finance expenses on lease liabilities		(3)
Amortization of intangible assets		384	347
Depreciation		6	3
Loss from change in the fair value of a financial asset at fair value		57	90
Equity losses	[1]	245	89
Change in fair value of derivative liabilities		730	(341)
Changes in deferred taxes, net		(27)	(27)
Issuance costs of financial instruments classified as derivative liabilities		603
Changes in operating assets and liabilities:
Decrease in trade receivables		233	196
Increase in related parties balance		(88)	(2)
Decrease (increase) in operating lease right-of-use assets		42	(30)
Increase (decrease) in operating lease liabilities		(42)	31
Decrease in other receivables		151	219
Increase in inventory		(1,968)	(752)
Increase (decrease) in accounts payable and other payables		13	790
Net cash used in operating activities		(3,534)	(1,169)
CASH FLOWS USED IN INVESTING ACTIVITIES:
Purchase of property and equipment		(8)	(8)
Purchase of investment accounted for using the equity method (see note 3.a)		(98)	(2,993)
Purchase of intangible asset (see note 5)		(330)	(1,682)
Net cash used in investing activities		(436)	(4,683)
CASH FLOWS FROM (USED IN) FINANCING ACTIVITIES:
Short term loan repaid			(86)
Issuance of ordinary shares, pre-funded warrants and warrants, net		6,255
Net cash from (used in) financing activities		6,255	(86)
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS		2,285	(5,938)
CASH AND CASH EQUIVALENTS AT BEGINNING OF THE PERIOD		535	8,137
LOSSES FROM EXCHANGE DIFFERENCES ON CASH AND CASH EQUIVALENTS		(5)	(46)
CASH AND CASH EQUIVALENTS AT END OF THE PERIOD		2,815	2,153
Supplemental disclosure of cash flow information:
Taxes paid		92	28
Interest paid			2
Supplemental disclosure of noncash investing and financing activities:
Issuance of ordinary shares to SciSparc Ltd. in consideration for ordinary shares (see note 3.b)			288
Consideration payable to sellers of Fort Products Ltd. included in other payables			349
Consideration payable to seller of SciSparc Nutraceuticals Inc. shares included in other payables			$ 41
[1] Except share and per share information

General Information

General Information	6 Months Ended
	Jun. 30, 2024
General Information [Abstract]
GENERAL INFORMATION	NOTE 1 — GENERAL INFORMATION a. General Jeffs’ Brands Ltd (the “ Company Jeffs’ Brands Smart Pro Top Rank Jeffs’ Brands Holdings Fort Fort US Subsidiaries Group Brands Amazon References to the Company hereinafter, unless the context otherwise provides, include Jeffs’ Brands and the Subsidiaries on a consolidated basis. Smart Pro, a corporation incorporated under the laws of the State of California, was established on December 20, 2017, and commenced its operations in June 2019. As of June 30, 2024, Smart Pro operated four Brands on the Amazon website. In April 2021, Top Rank, an Israeli company, was incorporated as a wholly owned subsidiary of Jeffs’ Brands. On February 23, 2023, Jeffs’ Brands Holdings was incorporated and registered under the laws of the State of Delaware as a wholly owned subsidiary of Jeffs’ Brands. On February 23, 2023, the Company purchased approximately 49% of the issued and outstanding shares of SciSparc Nutraceuticals Inc. (“ SciSparc U.S. On March 9, 2023, the Company purchased all of the issued and outstanding share capital of Fort, a company incorporated under the laws of England and Wales. For additional information see note 5. On April 23, 2023, Fort US was incorporated and registered under the laws of the State of Delaware as a wholly owned subsidiary of Jeffs’ Brands Holdings. b. Concentration Risk The Group’s activities are mainly conducted through Amazon’s commercial platform. Any material change, whether temporary or permanent, including changes in Amazon’s terms of use and/or its policies, may affect sales performance, and may have a material effect on the Group’s financial position and the results of its operations. In addition, the Group is engaged with a small number of suppliers as part of the production process of its brands. Any material changes in the supply process, whether temporary or permanent, may affect sales performance, and may have a material effect on the Group’s financial position and the results of its operations. c. Liquidity During the six months ended June 30, 2024, the Group incurred a net loss of $3,875 thousand and cash flows used in operating activities were $ 3,534 thousand. As of June 30, 2024, the Group had an accumulated deficit of approximately $12,151 thousand. The Group intends to continue to finance its operating activities through the sale of products via the Brands and through raising additional capital, as needed. On January 29, 2024, the Company completed a private placement transaction (the “ Private Placement The Company’s negative cash flow from operations resulted, among other things, from purchase of inventory of $4,001 thousand during the six months period ended June 30, 2024. While the Company generated negative cash flow from operations during the six months ended June 30, 2024, the Company’s management believes that its current cash resources of $1.53 million, together with the realization of inventory in the near future will generate sufficient cash flow for the Company to carry out its operations during the 12 months from September 30, 2024, the date of issuance of these financial statements.

Basis of Presentation and Signi

Basis of Presentation and Significant Accounting Policies	6 Months Ended
	Jun. 30, 2024
Basis of Presentation and Significant Accounting Policies [Abstract]
BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES	NOTE 2 — BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES a. Unaudited Interim Financial Statements The accompanying unaudited consolidated condensed financial statements have been prepared in accordance with U.S. generally accepted accounting principles (“ U.S. GAAP b. Principles of Consolidation The accompanying condensed consolidated financial statements include the accounts of the Group. All intercompany balances and transactions have been eliminated in consolidation. c. Use of estimates The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenue and expenses during the reporting period. The Company evaluates on an ongoing basis its assumptions, including those related to contingencies, deferred taxes, inventory impairment, derivative liability, useful lives of intangible assets, intangible assets impairment as well as in estimates used in applying the revenue recognition policy. Actual results may differ from those estimates. In the preparation of these condensed consolidated financial statements, the significant judgments exercised by management in the application of the Group’s accounting policies and the uncertainty involved in the key sources of those estimates were identical to the ones used in the Group’s consolidated financial statements for the year ended December 31, 2023. d. Significant Accounting Policies The significant accounting policies followed in the preparation of these unaudited interim condensed consolidated financial statements are identical to those applied in the preparation of the Group’s financial statements for the year ended December 31, 2023. e. Recent Accounting Pronouncements not yet adopted In December 2023, the Financial Accounting Standards Board (the “ FASB In November 2023, the FASB issued ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures. The ASU expands public entities’ segment disclosures by requiring disclosure of significant segment expenses that are regularly reviewed by the chief operating decision maker (“ CODM

Investment in Affiliate

Investment in Affiliate	6 Months Ended
	Jun. 30, 2024
Investment in Affiliate [Abstract]
INVESTMENT IN AFFILIATE	NOTE 3 — INVESTMENT IN AFFILIATE a. On February 23, 2023, the Company and Jeffs’ Brands Holdings entered into a stock purchase agreement (as amended on March 22, 2023, the “ Wellution Agreement SciSparc ASC 805 In connection with the closing of the Wellution Agreement, on March 22, 2023, the Company entered into a consulting agreement with SciSparc U.S. (the “ SciSparc Consulting Agreement Jeffs’ Brands Holdings owns 49% of the voting rights in SciSparc U.S and has the right to appoint two out of five directors. Management has determined that it has significant influence over SciSparc U.S and accordingly accounts for its investment under the equity method. The Company did not obtain any substantive processes, assembled workforce, or employees capable of producing outputs in connection with the acquisition. Therefore, the transaction was accounted for as an asset acquisition, as the acquired assets did not meet the definition of a business as defined by ASC 805, Business Combinations. The activity in the investment accounted for using the equity method was as follows: January 1, USD in Balance as of January 1, 2024 1,940 Equity losses (245 ) Balance as of June 30, 2024 1,695 Summarized financial information: Summarized statement of operations: January 1, 2024 – February 23, 2023 – USD in thousands Revenues 840 1,186 Net loss (500 ) (151 ) b. Pursuant to the Wellution Agreement, in connection with the closing of the Wellution Agreement, on March 22, 2023, the Company issued 35,345 ordinary shares, no Ordinary Shares Exchange Shares The investment in SciSparc was accounted for as financial asset through profit and loss. The activity in investment at fair value was as follows: January 1, USD in Balance as of January 1, 2024 67 Revaluation losses (56 ) Balance as of June 30, 2024 11

Significant Events During the P

Significant Events During the Period	6 Months Ended
	Jun. 30, 2024
Significant Events During the Period [Abstract]
SIGNIFICANT EVENTS DURING THE PERIOD	NOTE 4 — SIGNIFICANT EVENTS DURING THE PERIOD a. On January 25, 2024, the Company entered into a Securities Purchase Agreement with certain institutional investors for aggregate gross proceeds of $7.275 million, before deducting fees to the placement agent and other expenses payable by the Company in connection with the Private Placement. The Private Placement closed on January 29, 2024 (“ Issuance Date As part of the Securities Purchase Agreement, the Company issued an aggregate of (i) 1,884,461 Ordinary Shares; (ii) Pre-Funded Warrants to purchase up to 820,000 Ordinary Shares at an exercise price of $0.00001 per Ordinary Share; (iii) Series A Warrants to purchase up to 3,380,586 Ordinary Shares at an exercise price of $2.69 per Ordinary Share (subject to certain anti-dilution and share combination event protections) and have a term of sixty-six (66) months from the date of issuance; and (iv) Series B Warrants to purchase, upon the satisfaction of certain conditions, up to 7,994,181 Ordinary Shares at an exercise price of $0.00001 Ordinary Share (following the end of an adjustment period as further described below). The Pre-Funded Warrants are exercisable as of the date of the issuance and will not expire until exercised in full. L.I.A. Pure Capital Ltd. (“ Pure Capital The number of Ordinary Shares issuable under the Series A and Series B Warrant was subject to an adjustment determined by the trading price of the Ordinary Shares following the effectiveness of a resale registration statement (the “ Resale Registration Statement Following the effectiveness of the Resale Registration Statement, on March 11, 2024 (i) Series A Warrants are exercisable into a total number of 13,373,177 Ordinary Shares (subject to certain anti-dilution and share combination event protections) and have an exercise price of $0.68 per Ordinary Share; and (ii) Series B Warrants are exercisable into a total number of 7,904,181 Ordinary Shares at an exercise price of per Ordinary Share $0.00001, following the adjustment. Subsequent to such adjustment, the Series B Warrants have a term of sixty-six (66) months from the date of issuance. As of the date of these consolidated financial statements, pre-funded warrants to purchase 820,000 Ordinary Shares and Series B Warrants to purchase 5,257,127 Ordinary Shares were exercised for an aggregate issuance of 6,077,127 Ordinary Shares. In connection with the Private Placement, the Company also entered into a placement agent agreement (the “ Placement Agent Agreement Aegis b. On April 25, 2024, the Company received a written notification from the Listing Qualifications Department of the Nasdaq Stock Market LLC (“ Nasdaq Minimum Bid Price Requirement In the event that the Company does not regain compliance after the initial 180-day period, the Company may then be eligible for an additional 180-day compliance period if the Company meets the continued listing requirement for market value of publicly held shares and all other initial listing standards for Nasdaq.

Intangible Assets

Intangible Assets	6 Months Ended
	Jun. 30, 2024
Intangible Assets [Abstract]
INTANGIBLE ASSETS	NOTE 5 — INTANGIBLE ASSETS Total intangible assets consisted of the following as of June 30, 2024 and December 31, 2023: June 30, 2024 Gross Amount Accumulated Amortization Net Balance U.S. dollars in thousands Brands 7,774 (2,444 ) 5,330 December 31, 2023 Gross Amount Accumulated Amortization Net Balance U.S. dollars in thousands Brands 7,774 (2,060 ) 5,714 Amortization expense was $384 thousand and $347 thousand, for the six months ended June 30, 2024, and 2023, respectively. a. On March 2, 2023, the Company entered into a share purchase agreement (the “ Fort SPA Sellers Fort Acquisition On February 29, 2024, the Company entered into a side letter to the Fort SPA with the Sellers, pursuant to which the Company agreed to increase certain adjustment amount payments to the Sellers by approximately £100 thousand (approximately $128 thousand). On March 9, 2023, the Company recognized the amount of $1,991 thousand paid in connection with the Fort Acquisition amortized over a period of ten (10) years. As part of the Fort SPA, the employment of these employees was terminated within three months, with all termination costs to be borne by the Sellers. Also, in connection with the closing of the Fort Acquisition, on March 9, 2023, Fort and the Sellers entered into a consulting agreement, pursuant to which the Sellers will provide the Company with consultancy services for a period of six months following the closing, at a monthly fee of £2.5 thousand (approximately $3 thousand). On September 20, 2023, the Company and the Sellers entered into a new consulting agreement for indefinite period at a monthly fee of £3.5 thousand (approximately $4.5 thousand) effective as of June 1, 2023 (the “ Fort Consulting Agreement The Company did not obtain any substantive processes, assembled workforce, or employees capable of producing outputs in connection with the acquisition. Therefore, the transaction was accounted for as an asset acquisition, as the acquired assets did not meet the definition of a business as defined by ASC 805, Business Combinations.

Other Payables

Other Payables	6 Months Ended
	Jun. 30, 2024
Other Payables [Abstract]
OTHER PAYABLES	NOTE 6 — OTHER PAYABLES June 30, December 31, USD in thousands Government institutions 561 428 Employees and related benefits 120 85 Operating lease liabilities 69 82 Liability to sellers - (*) Revenue Sharing Payment payable 141 140 Accrued expenses and other payables 402 368 1,293 1,533 (*) Includes $98 thousand to SciSparc as of December 31, 2023. See Note 9 for additional information.

Derivative Liabilities

Derivative Liabilities	6 Months Ended
	Jun. 30, 2024
Derivative Liabilities [Abstract]
DERIVATIVE LIABILITIES	NOTE 7 — DERIVATIVE LIABILITIES Additional Warrants On November 28, 2022, the Company issued additional warrants (the “ Additional Warrants IPO Warrants Revenue Sharing Payment Additionally, the revenue forecast over the life of the Additional Warrants is a significant input in determining the price of the Additional Warrants as of June 30, 2024. Series A Warrants As part of the Private Placement, the Company issued Series A Warrants to purchase up to an aggregate of 3,380,586 Ordinary Shares at an exercise price of $2.69 per Ordinary Share (subject to certain anti-dilution and share combination event protections) as of the Issuance Date. Following effectiveness of the Resale Registration Statement, on March 11, 2024, the Series A Warrants are exercisable into an aggregate of 13,373,208 Ordinary Shares at an exercise price of $0.68 per Ordinary Share (subject to certain anti-dilution and share combination event protections). The Series A Warrants were immediately exercisable, and set to expire within sixty-six (66) months from the date of issuance. According to terms of the Series A Warrants, in an event of a Dilutive Issuance (as defined in the Series A Warrant) or a Share Combination Event (as defined in the Series A Warrant), if the lowest share price during the five consecutive trading days commencing on the date on which the Share Combination Event is effected is less than the exercise price per Ordinary Share (“ Exercise Price The Company determined that the Series A Warrants preclude equity classification due to the anti-dilutive protection feature. As such, the Series A Warrants were classified as a derivative liability. The derivative liability is recorded at fair value and amounted to $5,484 thousand as of June 30, 2024. The following table presents changes in the fair value of the derivative Series A Warrants and the Additional Warrants liability during the period (in thousands) Series A Warrants Additional Total Balance as of December 31, 2023 - 1,375 1,375 Issuance on January 29, 2024 4,301 - 4,301 Change in fair value 1,183 (453 ) 730 Balance as of June 30, 2024 5,484 922 6,406 The following table lists the significant unobservable inputs used for calculation of fair value of the Additional Warrants: June 30, December 31, Expected volatility 121.91 % 101.39 % Exercise price $ 14.14 14.14 Share price $ 0.30 3.05 Risk-free interest rate 4.47 % 3.93 % Dividend yield - - Expected life 3.41 3.91 Weighted average cost of capital (WACC) 20.7 % 20.4 % The following table lists the significant unobservable inputs used for calculation of fair value of Series A Warrants: June 30, Expected volatility 125.6 % Exercise price $ 0.68 Share price $ 0.30 Risk-free interest rate 4.33 % Dividend yield - Expected life 5.08

Financial Expenses (Income), Ne

Financial Expenses (Income), Net	6 Months Ended
	Jun. 30, 2024
Financial Expenses (Income), Net [Abstract]
FINANCIAL EXPENSES (INCOME), NET	NOTE 8 — FINANCIAL EXPENSES (INCOME), NET Six months ended 2024 2023 U.S. dollars in thousands Change in fair value of derivative liabilities 730 (341 ) Exchange rate differences 20 102 Interest income (60 ) (4 ) Issuance costs of financial instruments classified as derivative liabilities 603 - Revaluation of securities -fair value through profit or loss 57 90 Other finance expenses 17 5 1,367 (148 )

Related Parties _ Transactions

Related Parties — Transactions and Balances	6 Months Ended
	Jun. 30, 2024
Related Parties — Transactions and Balances [Abstract]
RELATED PARTIES — TRANSACTIONS AND BALANCES	NOTE 9 — RELATED PARTIES — TRANSACTIONS AND BALANCES a. Transactions with interested and related parties: Six months ended 2024 2023 U.S. dollars in thousands Labor cost and related expenses (included in general and administrative) (c1) 140 133 Inventory storage (included in cost of sale) (c2) 207 313 Consulting fees (included in general and administrative) (c2) 78 95 Consulting fees (included in general and administrative) (c3) 120 - Other income (c4) (60 ) (158 ) Revenue Sharing Payment (included in general and administrative) (c5) 21 19 506 402 b. Balances with interested and related parties: Period ended June 30, December 31, U.S. dollars in thousands ASSETS: Related parties (c4) 53 - 53 - LIABILITIES: Related parties (c7) 31 66 Chief executive officer salary (included in other account payable) (c1) 19 18 Revenue Sharing Payment (included in other account payable) (c5) 21 21 Liability to SciSparc (included in other account payable) (c6) - 98 Liability to Xylo (included in other account payable) (c3) 20 - Liability to supplier (included in trade payable) (c2) 33 69 Liability to consultant (included in other account payable and trade payable) (c2) 18 17 142 289 c. Additional information: 1. The Company's chief executive officer monthly salary is NIS 80 thousand (approximately $21 thousand) plus VAT. 2. On October 26, 2022, the Company and Pure Capital entered into a consulting agreement (the “ Pure Capital Consulting Agreement On February 5, 2024, the Company paid Pure Capital $100 thousand pursuant to the terms of Pure Capital Consulting Agreement in connection with the Company’s initial public offering. On September, 4, 2024, the Company and Pure Capital signed an amendment to the Pure Capital Consulting Agreement. According to the amendment Pure Capital will be entitled to a special bonus upon the consummation of an offering of securities of the Company, including proceeds received from exercise of warrants issued, according to the below distribution, which is based on gross proceeds: (i) up to $2.5 million, Pure Capital will be entitled to a bonus payment of $50,000; (ii) between $2.5 million and $5 million, Pure Capital will be entitled to a bonus payment of $100 thousand; (iii) between $5 million and $10 million, Pure Capital will be entitled to a bonus payment of $200 thousand; (iv) above $10 million, Pure Capital will be entitled to a bonus payment of $300 thousand, instead of 7% of the gross proceed paid to the Company. 3. On April 30, 2024, the Company entered into a consulting agreement (the “ Xylo Consulting Agreement Xylo 4. On March 22, 2023, the Company entered into a consulting agreement with SciSparc (the “ SciSparc Consulting Agreement 5. In April 2024, the Company paid $12 thousand to Xylo and $9 thousand to Pure Capital in connection to Revenue Sharing Payment. The outstanding payable to Xylo and Pure Capital as of June 30, 2024, is $12 thousand and $9 thousand, respectively. 6. The outstanding amount due to SciSparc in connection with the closing of the Wellution Agreement was $98 thousand. This amount was paid on January 31, 2024. 7. During the six months ended June 30, 2024 the Company paid to Xylo $25 thousand in connection with the outstanding payable amount related to Xylo employee services provided to the Company.

Subsequent Events

Subsequent Events	6 Months Ended
	Jun. 30, 2024
Subsequent Events [Abstract]
SUBSEQUENT EVENTS	NOTE 10 — SUBSEQUENT EVENTS a. On July 1, 2024, Fort entered into a lease agreement for a new warehouse in the UK. The lease agreement is for a period of five years and the annual rent fees £52,000. b. On July 17, 2024, the shareholders of the Company approved at the annual general meeting the following: (i) the re-election of the directors Liron Carmel and Eliyahu Yoresh until the close of the annual general meeting to be held in 2027, or earlier by resignation or removal, as applicable, (ii) the adoption of a new compensation policy for the Company’s executive officers and directors, (iii) the amendment to the articles of association of the Company, adoption of new compensation terms to each of the chairman and the chief executive officer of the Company, (iv) a reverse split of the Company’s issued and outstanding Ordinary Shares in a range between 1:2 and 1:22, to be affected at the discretion of, and at such ratio and on such date to be determined by, the board of directors and (v) the re-appointment of Brightman Almagor Zohar & Co., a firm in the Deloitte Global Network, as the Company’s independent registered public accounting firm for the year ending December 31, 2024 and until the next annual general meeting of shareholders.

Accounting Policies, by Policy

Accounting Policies, by Policy (Policies)	6 Months Ended
	Jun. 30, 2024
Basis of Presentation and Significant Accounting Policies [Abstract]
Unaudited Interim Financial Statements	a. Unaudited Interim Financial Statements The accompanying unaudited consolidated condensed financial statements have been prepared in accordance with U.S. generally accepted accounting principles (“ U.S. GAAP
Principles of Consolidation	b. Principles of Consolidation The accompanying condensed consolidated financial statements include the accounts of the Group. All intercompany balances and transactions have been eliminated in consolidation.
Use of estimates	c. Use of estimates The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenue and expenses during the reporting period. The Company evaluates on an ongoing basis its assumptions, including those related to contingencies, deferred taxes, inventory impairment, derivative liability, useful lives of intangible assets, intangible assets impairment as well as in estimates used in applying the revenue recognition policy. Actual results may differ from those estimates. In the preparation of these condensed consolidated financial statements, the significant judgments exercised by management in the application of the Group’s accounting policies and the uncertainty involved in the key sources of those estimates were identical to the ones used in the Group’s consolidated financial statements for the year ended December 31, 2023.
Significant Accounting Policies	d. Significant Accounting Policies The significant accounting policies followed in the preparation of these unaudited interim condensed consolidated financial statements are identical to those applied in the preparation of the Group’s financial statements for the year ended December 31, 2023.
Recent Accounting Pronouncements not yet adopted	e. Recent Accounting Pronouncements not yet adopted In December 2023, the Financial Accounting Standards Board (the “ FASB In November 2023, the FASB issued ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures. The ASU expands public entities’ segment disclosures by requiring disclosure of significant segment expenses that are regularly reviewed by the chief operating decision maker (“ CODM

Investment in Affiliate (Tables

Investment in Affiliate (Tables)	6 Months Ended
	Jun. 30, 2024
Investment in Affiliate [Abstract]
Schedule of Equity Method	The activity in the investment accounted for using the equity method was as follows: January 1, USD in Balance as of January 1, 2024 1,940 Equity losses (245 ) Balance as of June 30, 2024 1,695
Schedule of Statement of Operations	Summarized statement of operations: January 1, 2024 – February 23, 2023 – USD in thousands Revenues 840 1,186 Net loss (500 ) (151 )
Schedule of Activity in Investment at Fair Value	The activity in investment at fair value was as follows: January 1, USD in Balance as of January 1, 2024 67 Revaluation losses (56 ) Balance as of June 30, 2024 11

Intangible Assets (Tables)

Intangible Assets (Tables)	6 Months Ended
	Jun. 30, 2024
Intangible Assets [Abstract]
Schedule of Intangible Assets	Total intangible assets consisted of the following as of June 30, 2024 and December 31, 2023: June 30, 2024 Gross Amount Accumulated Amortization Net Balance U.S. dollars in thousands Brands 7,774 (2,444 ) 5,330 December 31, 2023 Gross Amount Accumulated Amortization Net Balance U.S. dollars in thousands Brands 7,774 (2,060 ) 5,714

Other Payables (Tables)

Other Payables (Tables)	6 Months Ended
	Jun. 30, 2024
Other Payables [Abstract]
Schedule of Other Payables	June 30, December 31, USD in thousands Government institutions 561 428 Employees and related benefits 120 85 Operating lease liabilities 69 82 Liability to sellers - (*) Revenue Sharing Payment payable 141 140 Accrued expenses and other payables 402 368 1,293 1,533 (*) Includes $98 thousand to SciSparc as of December 31, 2023. See Note 9 for additional information.

Derivative Liabilities (Tables)

Derivative Liabilities (Tables)	6 Months Ended
	Jun. 30, 2024
Derivative Liabilities [Abstract]
Schedule of Fair Value of the Derivative Series A Warrants and the Additional Warrants Liability	The following table presents changes in the fair value of the derivative Series A Warrants and the Additional Warrants liability during the period (in thousands) Series A Warrants Additional Total Balance as of December 31, 2023 - 1,375 1,375 Issuance on January 29, 2024 4,301 - 4,301 Change in fair value 1,183 (453 ) 730 Balance as of June 30, 2024 5,484 922 6,406
Schedule of Fair Value of the Additional Warrants	The following table lists the significant unobservable inputs used for calculation of fair value of the Additional Warrants: June 30, December 31, Expected volatility 121.91 % 101.39 % Exercise price $ 14.14 14.14 Share price $ 0.30 3.05 Risk-free interest rate 4.47 % 3.93 % Dividend yield - - Expected life 3.41 3.91 Weighted average cost of capital (WACC) 20.7 % 20.4 % June 30, Expected volatility 125.6 % Exercise price $ 0.68 Share price $ 0.30 Risk-free interest rate 4.33 % Dividend yield - Expected life 5.08

Financial Expenses (Income), _2

Financial Expenses (Income), Net (Tables)	6 Months Ended
	Jun. 30, 2024
Financial Expenses (Income), Net [Abstract]
Schedule of Financial Expenses (Income), Net	Six months ended 2024 2023 U.S. dollars in thousands Change in fair value of derivative liabilities 730 (341 ) Exchange rate differences 20 102 Interest income (60 ) (4 ) Issuance costs of financial instruments classified as derivative liabilities 603 - Revaluation of securities -fair value through profit or loss 57 90 Other finance expenses 17 5 1,367 (148 )

Related Parties _ Transaction_2

Related Parties — Transactions and Balances (Tables)	6 Months Ended
	Jun. 30, 2024
Related Parties — Transactions and Balances [Abstract]
Schedule of Transactions with Interested and Related Parties	Transactions with interested and related parties: Six months ended 2024 2023 U.S. dollars in thousands Labor cost and related expenses (included in general and administrative) (c1) 140 133 Inventory storage (included in cost of sale) (c2) 207 313 Consulting fees (included in general and administrative) (c2) 78 95 Consulting fees (included in general and administrative) (c3) 120 - Other income (c4) (60 ) (158 ) Revenue Sharing Payment (included in general and administrative) (c5) 21 19 506 402 1. The Company's chief executive officer monthly salary is NIS 80 thousand (approximately $21 thousand) plus VAT. 2. On October 26, 2022, the Company and Pure Capital entered into a consulting agreement (the “ Pure Capital Consulting Agreement On February 5, 2024, the Company paid Pure Capital $100 thousand pursuant to the terms of Pure Capital Consulting Agreement in connection with the Company’s initial public offering. On September, 4, 2024, the Company and Pure Capital signed an amendment to the Pure Capital Consulting Agreement. According to the amendment Pure Capital will be entitled to a special bonus upon the consummation of an offering of securities of the Company, including proceeds received from exercise of warrants issued, according to the below distribution, which is based on gross proceeds: (i) up to $2.5 million, Pure Capital will be entitled to a bonus payment of $50,000; (ii) between $2.5 million and $5 million, Pure Capital will be entitled to a bonus payment of $100 thousand; (iii) between $5 million and $10 million, Pure Capital will be entitled to a bonus payment of $200 thousand; (iv) above $10 million, Pure Capital will be entitled to a bonus payment of $300 thousand, instead of 7% of the gross proceed paid to the Company. 3. On April 30, 2024, the Company entered into a consulting agreement (the “ Xylo Consulting Agreement Xylo 4. On March 22, 2023, the Company entered into a consulting agreement with SciSparc (the “ SciSparc Consulting Agreement 5. In April 2024, the Company paid $12 thousand to Xylo and $9 thousand to Pure Capital in connection to Revenue Sharing Payment. The outstanding payable to Xylo and Pure Capital as of June 30, 2024, is $12 thousand and $9 thousand, respectively.
Schedule of Balances with Interested and Related Parties	Balances with interested and related parties: Period ended June 30, December 31, U.S. dollars in thousands ASSETS: Related parties (c4) 53 - 53 - LIABILITIES: Related parties (c7) 31 66 Chief executive officer salary (included in other account payable) (c1) 19 18 Revenue Sharing Payment (included in other account payable) (c5) 21 21 Liability to SciSparc (included in other account payable) (c6) - 98 Liability to Xylo (included in other account payable) (c3) 20 - Liability to supplier (included in trade payable) (c2) 33 69 Liability to consultant (included in other account payable and trade payable) (c2) 18 17 142 289 1. The Company's chief executive officer monthly salary is NIS 80 thousand (approximately $21 thousand) plus VAT. 2. On October 26, 2022, the Company and Pure Capital entered into a consulting agreement (the “ Pure Capital Consulting Agreement On February 5, 2024, the Company paid Pure Capital $100 thousand pursuant to the terms of Pure Capital Consulting Agreement in connection with the Company’s initial public offering. On September, 4, 2024, the Company and Pure Capital signed an amendment to the Pure Capital Consulting Agreement. According to the amendment Pure Capital will be entitled to a special bonus upon the consummation of an offering of securities of the Company, including proceeds received from exercise of warrants issued, according to the below distribution, which is based on gross proceeds: (i) up to $2.5 million, Pure Capital will be entitled to a bonus payment of $50,000; (ii) between $2.5 million and $5 million, Pure Capital will be entitled to a bonus payment of $100 thousand; (iii) between $5 million and $10 million, Pure Capital will be entitled to a bonus payment of $200 thousand; (iv) above $10 million, Pure Capital will be entitled to a bonus payment of $300 thousand, instead of 7% of the gross proceed paid to the Company. 3. On April 30, 2024, the Company entered into a consulting agreement (the “ Xylo Consulting Agreement Xylo 4. On March 22, 2023, the Company entered into a consulting agreement with SciSparc (the “ SciSparc Consulting Agreement 5. In April 2024, the Company paid $12 thousand to Xylo and $9 thousand to Pure Capital in connection to Revenue Sharing Payment. The outstanding payable to Xylo and Pure Capital as of June 30, 2024, is $12 thousand and $9 thousand, respectively. 6. The outstanding amount due to SciSparc in connection with the closing of the Wellution Agreement was $98 thousand. This amount was paid on January 31, 2024. 7. During the six months ended June 30, 2024 the Company paid to Xylo $25 thousand in connection with the outstanding payable amount related to Xylo employee services provided to the Company.

General Information (Details)

General Information (Details) - USD ($) $ in Thousands				6 Months Ended
		Jan. 29, 2024	Feb. 23, 2023	Jun. 30, 2024	Jun. 30, 2023	Dec. 31, 2023
General Information [Line Items]
Date of incorporation				Mar. 07, 2021
Purchase of issued and outstanding shares percentage			49%
Net loss	[1]			$ (3,875)	$ (1,828)
Cash flows used in operating activities				(3,534)	$ (1,169)
Accumulated deficit				(12,151)		$ (8,276)
Aggregate gross proceeds		$ 7,275
Purchase of inventory				4,001
Current cash resources				$ 1,530
[1] Except share and per share information

Investment in Affiliate (Detail

Investment in Affiliate (Details) - USD ($) $ / shares in Thousands, $ in Thousands				1 Months Ended	6 Months Ended
	Sep. 28, 2023	Mar. 22, 2023	Feb. 23, 2023	Nov. 30, 2023	Jun. 30, 2024	Dec. 31, 2023
Investment in Affiliate (Details) [Line Items]
Shares of common stock					9,177,100	1,215,512
Ordinary shares issued and outstanding, percentage		4.99%	49%
Fee amount				$ 10
Bonus amount					$ 51
Par value per share
Reverse share split	1-for-26
SciSparc Ltd [Member]
Investment in Affiliate (Details) [Line Items]
Shares of common stock		13,858	57
Ordinary shares issued and outstanding, percentage		2.97%
Cash			$ 3,000
Jeffs Brands Holding [Member]
Investment in Affiliate (Details) [Line Items]
Percentage of voting rights					49%
SciSparc Consulting Agreement [Member]
Investment in Affiliate (Details) [Line Items]
Fee amount				$ 10	$ 20
Wellution Agreement [Member]
Investment in Affiliate (Details) [Line Items]
Shares of common stock		35,345
Par value per share
Average closing price		$ 288

Investment in Affiliate (Deta_2

Investment in Affiliate (Details) - Schedule of Equity Method - USD ($) $ in Thousands		6 Months Ended
		Jun. 30, 2024	Jun. 30, 2023
Schedule Of Equity Method Abstract
Balance as of January 1, 2024		$ 1,940
Equity losses	[1]	(245)	$ (89)
Balance as of June 30, 2024		$ 1,695
[1] Except share and per share information

Investment in Affiliate (Deta_3

Investment in Affiliate (Details) - Schedule of Statement of Operations - Wellution [Member] - USD ($) $ in Thousands	4 Months Ended	6 Months Ended
	Jun. 30, 2023	Jun. 30, 2024
Condensed Income Statements, Captions [Line Items]
Revenues	$ 1,186	$ 840
Net loss	$ (151)	$ (500)

Investment in Affiliate (Deta_4

Investment in Affiliate (Details) - Schedule of Activity in Investment at Fair Value $ in Thousands	6 Months Ended
	Jun. 30, 2024 USD ($)
Schedule Of Activity In Investment At Fair Value Abstract
Balance as of January 1, 2024	$ 67
Revaluation losses	(56)
Balance as of June 30, 2024	$ 11

Significant Events During the_2

Significant Events During the Period (Details) - USD ($) $ / shares in Units, $ in Thousands				6 Months Ended
	Apr. 25, 2024	Jan. 29, 2024	Jan. 25, 2024	Jun. 30, 2024	Mar. 11, 2024	Nov. 28, 2022
Significant Events During the Period [Line Items]
Gross proceeds (in Dollars)		$ 7,275
Issuance of ordinary shares				6,077,127
Warrant to purchase shares			7,994,181
Warrants term			66 months	66 months	66 months
Pricing floor (in Dollars per Share)			0.68
Percentage of gross cash proceeds				8.50%
Payment for legal expenses (in Dollars)				$ 90
Closing bid price per share (in Dollars per share)	$ 1
Pure Capital Ltd. [Member]
Significant Events During the Period [Line Items]
Purchased of private placement (in Dollars)				$ 300
Pre-Funded Warrants [Member]
Significant Events During the Period [Line Items]
Warrant to purchase shares			820,000	820,000
Exercise price of per share (in Dollars per share)			$ 0.00001
Series A Warrants [Member]
Significant Events During the Period [Line Items]
Warrant to purchase shares			3,380,586		13,373,177
Exercise price of per share (in Dollars per share)			$ 2.69	$ 0.68	$ 0.68
Series B Warrants [Member]
Significant Events During the Period [Line Items]
Warrant to purchase shares			7,994,181	5,257,127	7,904,181
Exercise price of per share (in Dollars per share)			$ 0.00001		$ 0.00001
Ordinary Shares [Member]
Significant Events During the Period [Line Items]
Warrant to purchase shares						403,504
Closing bid price per share (in Dollars per share)	$ 1
Private Placement [Member]
Significant Events During the Period [Line Items]
Gross proceeds (in Dollars)			$ 7,275
Issuance of ordinary shares			1,884,461
Private Placement [Member] | Series A Warrants [Member]
Significant Events During the Period [Line Items]
Warrant to purchase shares				3,380,586
Private Placement [Member] | Ordinary Shares [Member]
Significant Events During the Period [Line Items]
Warrant to purchase shares				2.69
Resale Registration Statement [Member] | Series A Warrants [Member]
Significant Events During the Period [Line Items]
Warrant to purchase shares			13,373,177

Intangible Assets (Details)

Intangible Assets (Details)							6 Months Ended
	Feb. 29, 2024 USD ($)	Feb. 29, 2024 GBP (£)	Sep. 20, 2023 USD ($)	Sep. 20, 2023 GBP (£)	Mar. 09, 2023 USD ($)	Mar. 09, 2023 GBP (£)	Jun. 30, 2024 USD ($)	Jun. 30, 2023 USD ($)	Mar. 09, 2024 USD ($)	Mar. 09, 2023 GBP (£)
Intangible Assets (Details) [Line Items]
Amortization expense							$ 384,000	$ 347,000
Share capital outstanding (in Pounds) | £										£ 2,000,000
Payments to sellers | £		£ 100,000
Recognized amount									$ 1,991,000
Consultancy fee			$ 4,500	£ 3,500	$ 3,000	£ 2,500
Acquisition amortized					10 years					10 years
Fort Acquisition [Member]
Intangible Assets (Details) [Line Items]
Share capital issued					$ 2,400,000
Fort SPA [Member]
Intangible Assets (Details) [Line Items]
Payments to sellers	$ 128,000

Intangible Assets (Details) - S

Intangible Assets (Details) - Schedule of Intangible Assets - Brands [Member] - USD ($) $ in Thousands	Jun. 30, 2024	Dec. 31, 2023
Schedule of Intangible Assets [Line Items]
Gross Amount	$ 7,774	$ 7,774
Accumulated Amortization	(2,444)	(2,060)
Net Balance	$ 5,330	$ 5,714

Other Payables (Details)

Other Payables (Details) $ in Thousands	Dec. 31, 2023 USD ($)
Other Payables [Abstract]
Other payables	$ 98

Other Payables (Details) - Sche

Other Payables (Details) - Schedule of Other Payables - USD ($) $ in Thousands	Jun. 30, 2024	Dec. 31, 2023
Schedule of Other Payables [Abstract]
Government institutions	$ 561	$ 428
Employees and related benefits	120	85
Operating lease liabilities	69	82
Liability to sellers		430	[1]
Revenue Sharing Payment payable	141	140
Accrued expenses and other payables	402	368
Total	$ 1,293	$ 1,533
[1]Includes $98 thousand to SciSparc as of December 31, 2023. See Note 9 for additional information.

Derivative Liabilities (Details

Derivative Liabilities (Details) - USD ($) $ / shares in Units, $ in Thousands		6 Months Ended
	Nov. 28, 2022	Jun. 30, 2024	Mar. 11, 2024	Jan. 25, 2024
Derivative Liabilities [Line Items]
Purchase shares				7,994,181
Warrant term		66 months	66 months	66 months
Percentage of gross revenues	2.30%
Revenue sharing payment percentage		2.30%
Derivative liability (in Dollars)		$ 922
Additional Warrants [Member]
Derivative Liabilities [Line Items]
Warrant term	5 years
Series A Warrants [Member]
Derivative Liabilities [Line Items]
Purchase shares			13,373,177	3,380,586
Derivative liability (in Dollars)		$ 5,484
Number of warrants exercisable		13,373,208
Exercise price (in Dollars per share)		$ 0.68	$ 0.68	$ 2.69
Common Stock [Member]
Derivative Liabilities [Line Items]
Purchase shares	403,504
Private Placement [Member] | Series A Warrants [Member]
Derivative Liabilities [Line Items]
Purchase shares		3,380,586
Private Placement [Member] | Common Stock [Member]
Derivative Liabilities [Line Items]
Purchase shares		2.69

Derivative Liabilities (Detai_2

Derivative Liabilities (Details) - Schedule of Fair Value of the Derivative Series A Warrants and the Additional Warrants Liability - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023
Schedule of Fair Value of the Derivative Series A Warrants and the Additional Warrants Liability [Line Items]
Balance at beginning	$ 1,375
Issuance on January 29, 2024	4,301
Change in fair value	730	$ (341)
Balance at ending	6,406
Series A Warrants [Member]
Schedule of Fair Value of the Derivative Series A Warrants and the Additional Warrants Liability [Line Items]
Balance at beginning
Issuance on January 29, 2024	4,301
Change in fair value	1,183
Balance at ending	5,484
Additional Warrants [Member]
Schedule of Fair Value of the Derivative Series A Warrants and the Additional Warrants Liability [Line Items]
Balance at beginning	1,375
Issuance on January 29, 2024
Change in fair value	(453)
Balance at ending	$ 922

Derivative Liabilities (Detai_3

Derivative Liabilities (Details) - Schedule of Fair Value of the Additional Warrants	Jun. 30, 2024	Jun. 30, 2023
Expected volatility [Member] | Additional Warrants [Member]
Schedule of Fair Value of the Additional Warrants [Line Items]
Measurement Input, Derivative Liability	121.91	101.39
Expected volatility [Member] | Series A Warrants [Member]
Schedule of Fair Value of the Additional Warrants [Line Items]
Measurement Input, Derivative Liability	125.6
Exercise price [Member] | Additional Warrants [Member]
Schedule of Fair Value of the Additional Warrants [Line Items]
Measurement Input, Derivative Liability	14.14	14.14
Exercise price [Member] | Series A Warrants [Member]
Schedule of Fair Value of the Additional Warrants [Line Items]
Measurement Input, Derivative Liability	0.68
Share price [Member] | Additional Warrants [Member]
Schedule of Fair Value of the Additional Warrants [Line Items]
Measurement Input, Derivative Liability	0.3	3.05
Share price [Member] | Series A Warrants [Member]
Schedule of Fair Value of the Additional Warrants [Line Items]
Measurement Input, Derivative Liability	0.3
Risk-free interest rate [Member] | Additional Warrants [Member]
Schedule of Fair Value of the Additional Warrants [Line Items]
Measurement Input, Derivative Liability	4.47	3.93
Risk-free interest rate [Member] | Series A Warrants [Member]
Schedule of Fair Value of the Additional Warrants [Line Items]
Measurement Input, Derivative Liability	4.33
Dividend yield [Member] | Additional Warrants [Member]
Schedule of Fair Value of the Additional Warrants [Line Items]
Measurement Input, Derivative Liability
Dividend yield [Member] | Series A Warrants [Member]
Schedule of Fair Value of the Additional Warrants [Line Items]
Measurement Input, Derivative Liability
Expected life [Member] | Additional Warrants [Member]
Schedule of Fair Value of the Additional Warrants [Line Items]
Measurement Input, Derivative Liability	3.41	3.91
Expected life [Member] | Series A Warrants [Member]
Schedule of Fair Value of the Additional Warrants [Line Items]
Measurement Input, Derivative Liability	5.08
Weighted average cost of capital (WACC) [Member] | Additional Warrants [Member]
Schedule of Fair Value of the Additional Warrants [Line Items]
Measurement Input, Derivative Liability	20.7	20.4

Financial Expenses (Income), _3

Financial Expenses (Income), Net (Details) - Schedule of Financial Expenses (Income), Net - USD ($) $ in Thousands		6 Months Ended
		Jun. 30, 2024	Jun. 30, 2023
Schedule of Financial Expenses (Income), Net [Abstract]
Change in fair value of derivative liabilities		$ 730	$ (341)
Exchange rate differences		20	102
Interest income		(60)	(4)
Issuance costs of financial instruments classified as derivative liabilities		603
Revaluation of securities -fair value through profit or loss		57	90
Other finance expenses		17	5
Total	[1]	$ 1,367	$ (148)
[1] Except share and per share information

Related Parties _ Transaction_3

Related Parties — Transactions and Balances (Details) $ in Thousands

1 Months Ended

6 Months Ended

Apr. 30, 2024 USD ($)

Feb. 05, 2024 USD ($)

Jan. 31, 2024 USD ($)

Mar. 22, 2023 USD ($)

Apr. 30, 2024 USD ($)

Nov. 30, 2023 USD ($)

Mar. 31, 2023 USD ($)

Oct. 26, 2022 USD ($)

Oct. 26, 2022 ILS (₪)

Jun. 30, 2024 USD ($)

Jun. 30, 2024 ILS (₪)

Jun. 30, 2023 USD ($)

Related Parties — Transactions and Balances [Line Items]

Consultancy services fees

$ 20

$ 16

₪ 57,750

Percentage of gross proceed

7%

7%

Percentage of total consideration paid

8%

8%

Paid to pure capital

$ 352

Payment to related party

$ 506

$ 402

Related party transaction, description

(i) up to $2.5 million, Pure Capital will be entitled to a bonus payment of $50,000; (ii) between $2.5 million and $5 million, Pure Capital will be entitled to a bonus payment of $100 thousand; (iii) between $5 million and $10 million, Pure Capital will be entitled to a bonus payment of $200 thousand; (iv) above $10 million, Pure Capital will be entitled to a bonus payment of $300 thousand, instead of 7% of the gross proceed paid to the Company.

(i) up to $2.5 million, Pure Capital will be entitled to a bonus payment of $50,000; (ii) between $2.5 million and $5 million, Pure Capital will be entitled to a bonus payment of $100 thousand; (iii) between $5 million and $10 million, Pure Capital will be entitled to a bonus payment of $200 thousand; (iv) above $10 million, Pure Capital will be entitled to a bonus payment of $300 thousand, instead of 7% of the gross proceed paid to the Company.

Bonus amount

$ 51

Advance Notice Period

30 years

30 days

Monthly fee

$ 10

Outstanding payable related to employee services

$ 25

Consulting agreement, term

36 days

Pure Capital Ltd. [Member]

Related Parties — Transactions and Balances [Line Items]

Related party, debts

$ 9

Outstanding payable

9

SciSparc Consulting Agreement [Member]

Related Parties — Transactions and Balances [Line Items]

Consultancy services fees

$ 20

Amount of outstanding due

$ 98

Xylo Technologies Ltd [Member]

Related Parties — Transactions and Balances [Line Items]

Related party, debts

$ 12

Outstanding payable

12

Chief Executive Officer [Member]

Related Parties — Transactions and Balances [Line Items]

Monthly salary

$ 21

₪ 80,000

IPO [Member] | Pure Capital Ltd. [Member]

Related Parties — Transactions and Balances [Line Items]

Payment to related party

$ 100

Related Parties _ Transaction_4

Related Parties — Transactions and Balances (Details) - Schedule of Transactions with Interested and Related Parties - USD ($) $ in Thousands		6 Months Ended
		Jun. 30, 2024	Jun. 30, 2023
Schedule of Transactions with Interested and Related Parties [Abstract]
Labor cost and related expenses (included in general and administrative) (c1)	[1]	$ 140	$ 133
Inventory storage (included in cost of sale) (c2)	[2]	207	313
Consulting fees (included in general and administrative) (c2)	[2]	78	95
Consulting fees (included in general and administrative) (c3)	[3]	120
Other income (c4)	[4]	(60)	(158)
Revenue Sharing Payment (included in general and administrative) (c5)	[5]	21	19
Total transactions with interested and related parties		$ 506	$ 402
[1]The Company's chief executive officer monthly salary is NIS 80 thousand (approximately $21 thousand) plus VAT.[2]On October 26, 2022, the Company and Pure Capital entered into a consulting agreement (the “Pure Capital Consulting Agreement”) pursuant to which Pure Capital will provide consultancy services to the Company for a monthly fee of NIS 57.75 thousand (approximately $16 thousand). Pursuant to the Pure Capital Consulting Agreement, Pure Capital is also entitled during the term of the Pure Capital Consulting Agreement to the following payments: (i) an amount equal to 7% of the gross proceeds paid to the Company in connection with any exercise of warrants, whether or not currently outstanding, and (ii) 8% of the total consideration paid in connection with any purchase of a new brand, businesses, or similar events initiated or assisted by Pure Capital and approved by the Chief Executive Officer and Chairman of the board of directors based on the Pure Capital Consulting Agreement. In March 2023, the Company paid Pure Capital $352 thousand in accordance with the terms of the Pure Capital Consulting Agreement. The consultancy fees were paid in consideration for the investments in Fort and SciSparc. Additionally, on October 26, 2022, the Company and Pure NJ Logistics LLC, a company wholly-owned by Pure Capital and a director of the Company, entered into a warehouse storage agreement located in New Jersey. On February 5, 2024, the Company paid Pure Capital $100 thousand pursuant to the terms of Pure Capital Consulting Agreement in connection with the Company’s initial public offering. On September, 4, 2024, the Company and Pure Capital signed an amendment to the Pure Capital Consulting Agreement. According to the amendment Pure Capital will be entitled to a special bonus upon the consummation of an offering of securities of the Company, including proceeds received from exercise of warrants issued, according to the below distribution, which is based on gross proceeds: (i) up to $2.5 million, Pure Capital will be entitled to a bonus payment of $50,000; (ii) between $2.5 million and $5 million, Pure Capital will be entitled to a bonus payment of $100 thousand; (iii) between $5 million and $10 million, Pure Capital will be entitled to a bonus payment of $200 thousand; (iv) above $10 million, Pure Capital will be entitled to a bonus payment of $300 thousand, instead of 7% of the gross proceed paid to the Company.[3]On April 30, 2024, the Company entered into a consulting agreement (the “ Xylo Consulting Agreement Xylo On March 22, 2023, the Company entered into a consulting agreement with SciSparc (the “ SciSparc Consulting Agreement

Related Parties _ Transaction_5

Related Parties — Transactions and Balances (Details) - Schedule of Balances with Interested and Related Parties - Related Party [Member] - USD ($) $ in Thousands		Jun. 30, 2024	Dec. 31, 2023
ASSETS:
Related parties		$ 53
LIABILITIES:
Liabilities		142	289
Related Party [Member]
ASSETS:
Related parties	[1]	53
LIABILITIES:
Liabilities	[2]	31	66
Chief Executive Officer Salary [Member]
LIABILITIES:
Included in other account payable	[3]	19	18
Revenue Sharing Payment [Member]
LIABILITIES:
Included in other account payable	[4]	21	21
Liability to SciSparc [Member]
LIABILITIES:
Included in other account payable	[5]		98
Liability to Xylo [Member]
LIABILITIES:
Included in other account payable	[6]	20
Liability to Supplier [Member]
LIABILITIES:
Included in trade payable	[7]	33	69
Liability to Consultant [Member]
LIABILITIES:
Included in other account payable	[7]	$ 18	$ 17
[1] On March 22, 2023, the Company entered into a consulting agreement with SciSparc (the “ SciSparc Consulting Agreement Xylo Consulting Agreement Xylo

Subsequent Events (Details)

Subsequent Events (Details) - Subsequent Event [Member]		1 Months Ended
	Jul. 01, 2024 GBP (£)	Jul. 17, 2024
Subsequent Events [Line Items]
Annual rent fees (in Pounds)	£ 52,000
Board of Directors Chairman [Member] | Minimum [Member]
Subsequent Events [Line Items]
Reverse split		1
Board of Directors Chairman [Member] | Maximum [Member]
Subsequent Events [Line Items]
Reverse split		2
Chief Executive Officer [Member] | Minimum [Member]
Subsequent Events [Line Items]
Reverse split		1
Chief Executive Officer [Member] | Maximum [Member]
Subsequent Events [Line Items]
Reverse split		22